Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays.
Finding new peptide biomarkers for stomach cancer in human sera that can be implemented into a clinically practicable prediction method for monitoring of stomach cancer. We studied the serum peptidome from two different biorepositories. We first employed a C8-reverse phase liquid chromatography approach for sample purification, followed by mass-spectrometry analysis. These were applied onto serum samples from cancer-free controls and stomach cancer patients at various clinical stages. We then created a bioinformatics analysis pipeline and identified peptide signature discriminating stomach adenocarcinoma patients from cancer-free controls. Matrix Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) results from 103 samples revealed 9 signature peptides; with prediction accuracy of 89% in the training set and 88% in the validation set. Three of the discriminating peptides discovered were fragments of Apolipoproteins C-I and C-III (apoC-I and C-III); we further quantified their serum levels, as well as CA19-9 and CRP, employing quantitative commercial-clinical assays in 142 samples. ApoC-I and apoC-III quantitative results correlated with the MS results. We then employed apoB-100-normalized apoC-I and apoC-III, CA19-9 and CRP levels to generate rules set for stomach cancer prediction. For training, we used sera from one repository, and for validation, we used sera from the second repository. Prediction accuracies of 88.4% and 74.4% were obtained in the training and validation sets, respectively. Serum levels of apoC-I and apoC-III combined with other clinical parameters can serve as a basis for the formulation of a diagnostic score for stomach cancer patients.
The Shraga Segal Department of Microbiology and Immunology and the National Institute for Biotechnology in the Negev, Ben Gurion University of the Negev, Beer Sheva, Israel.
Meital
M
Cohen
Rami
R
Yossef
Tamir
T
Erez
Aleksandra
A
Kugel
Michael
M
Welt
Mark M
MM
Karpasas
Jonathan
J
Bones
Pauline M
PM
Rudd
Julien
J
Taieb
Herve
H
Boissin
Dror
D
Harats
Karin
K
Noy
Yoram
Y
Tekoah
Rachel G
RG
Lichtenstein
Eitan
E
Rubin
Angel
A
Porgador
D000368:Aged; D053302:Apolipoprotein C-I / Q000097:blood*; D053305:Apolipoprotein C-III / Q000097:blood*; D001185:Artificial Intelligence; D014408:Biomarkers, Tumor / Q000097:blood; D016022:Case-Control Studies; D019295:Computational Biology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D040901:Proteomics / Q000379:methods*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013274:Stomach Neoplasms / Q000737:chemistry* / Q000175:diagnosis*
D053302:Apolipoprotein C-I; D053305:Apolipoprotein C-III; D014408:Biomarkers, Tumor
Ann N Y Acad Sci. 2004 Jun;1022:286-94
15251974
World J Gastroenterol. 2006 Dec 21;12(47):7604-12
17171788
Clin Chem. 2008 Jan;54(1):53-60
18024530
World J Gastroenterol. 2006 Mar 14;12(10):1536-44
16570345
J Clin Invest. 2006 Jan;116(1):26-30
16395400
J Chromatogr A. 2007 Aug 31;1162(2):117-25
17434173
Clin Chem. 2006 Jul;52(7):1223-37
16644871
Nat Rev Cancer. 2006 Dec;6(12):961-7
17093504
Mol Cell Proteomics. 2006 Oct;5(10):1840-52
16896061
J Natl Cancer Inst. 2001 Jul 18;93(14):1054-61
11459866
Nat Genet. 2002 Dec;32 Suppl:496-501
12454644
Clin Chem. 2006 Jul;52(7):1218-22
16675505
Rapid Commun Mass Spectrom. 2007;21(1):44-58
17133622
Cancer Res. 2004 Aug 15;64(16):5882-90
15313933
J Proteome Res. 2003 Jul-Aug;2(4):361-72
12938926
Clin Chem. 2008 Jan;54(1):44-52
17981926
Mol Cell Proteomics. 2002 Nov;1(11):845-67
12488461
Asian J Androl. 2009 May;11(3):299-307
19182819
Mol Cell Proteomics. 2004 Apr;3(4):367-78
14990683
Clin Chem. 1999 Oct;45(10):1695-707
10508114
J Clin Invest. 2006 Jan;116(1):271-84
16395409
J Proteome Res. 2005 Jul-Aug;4(4):1060-72
16083255
Nat Biotechnol. 2005 Mar;23(3):291-2
15765078
Nat Protoc. 2007;2(3):588-602
17406620
Dis Markers. 2003-2004;19(4-5):239-49
15266667
Prev Med. 2002 Jul;35(1):42-7
12079439
Nature. 2004 Jun 3;429(6991):496-7
15175721
Dis Markers. 2003-2004;19(4-5):185-95
15258333
J Proteome Res. 2009 Feb;8(2):694-701
19035662
J Proteome Res. 2005 May-Jun;4(3):972-81
15952745
Proteomics. 2008 Aug;8(16):3284-93
18646009
Nat Rev Cancer. 2005 Feb;5(2):142-9
15685197
Anal Chem. 2004 Mar 15;76(6):1560-70
15018552
Nat Protoc. 2006;1(2):880-91
17406321
Bioinformatics. 2008 Jun 1;24(11):1418-9
18400772